Literature DB >> 21416489

Activation of central trigeminovascular neurons by cortical spreading depression.

Xichun Zhang1, Dan Levy, Vanessa Kainz, Rodrigo Noseda, Moshe Jakubowski, Rami Burstein.   

Abstract

OBJECTIVE: Cortical spreading depression (CSD) has long been implicated in migraine attacks that begin with visual aura. Having shown that a wave of CSD can trigger long-lasting activation of meningeal nociceptors--the first-order neurons of the trigeminovascular pathway thought to underlie migraine headache--we now report that CSD can activate central trigeminovascular neurons in the spinal trigeminal nucleus (C1-2).
METHODS: Stimulation of the cortex with pinprick or KCl granule was used to induce CSD in anesthetized rats. Neuronal activity was monitored in C1-2 using single-unit recording.
RESULTS: In 25 trigeminovascular neurons activated by CSD, mean firing rate (spikes/s) increased from 3.6 ± 1.2 before CSD (baseline) to 6.1 ± 1.8 after CSD (p < 0.0001) for a period >13 minutes. Neuronal activity returned to baseline level after 30.0 ± 3.1 minutes in 14 units, and remained elevated for 66.0 ± 8.3 (22-108) minutes through the entire recording period in the other 11 units. Neuronal activation began within 0.9 ± 0.4 (0-2.5) minutes after CSD in 7 neurons located in laminae I-II, or after a latency of 25.1 ± 4.0 (7-75) minutes in 9 neurons located in laminae I-II, and 9 neurons located in laminae III-V. In 27 trigeminovascular neurons not activated by CSD, mean firing rate was 2.0 ± 0.7 at baseline and 1.8 ± 0.7 after CSD.
INTERPRETATION: We propose that CSD constitutes a nociceptive stimulus capable of activating peripheral and central trigeminovascular neurons that underlie the headache of migraine with aura.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Year:  2011        PMID: 21416489      PMCID: PMC3174689          DOI: 10.1002/ana.22329

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  60 in total

1.  Projections from the marginal zone and deep dorsal horn to the ventrobasal nuclei of the primate thalamus.

Authors:  W D Willis; X Zhang; C N Honda; G J Giesler
Journal:  Pain       Date:  2001-05       Impact factor: 6.961

2.  A critical review of the role of the proposed VMpo nucleus in pain.

Authors:  William D Willis; Xijing Zhang; Christopher N Honda; Glenn J Giesler
Journal:  J Pain       Date:  2002-04       Impact factor: 5.820

3.  Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma.

Authors:  A B Malmberg; C Chen; S Tonegawa; A I Basbaum
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

Review 4.  Tackling pain at the source: new ideas about nociceptors.

Authors:  W D Snider; S B McMahon
Journal:  Neuron       Date:  1998-04       Impact factor: 17.173

5.  Platelet glycine, glutamate and aspartate in primary headache.

Authors:  G D'Andrea; A R Cananzi; R Joseph; M Morra; F Zamberlan; F Ferro Milone; S Grunfeld; K M Welch
Journal:  Cephalalgia       Date:  1991-09       Impact factor: 6.292

6.  Sensory innervation of the calvarial bones of the mouse.

Authors:  Bela Kosaras; Moshe Jakubowski; Vanessa Kainz; Rami Burstein
Journal:  J Comp Neurol       Date:  2009-07-20       Impact factor: 3.215

7.  Cortical spreading depression-new insights and persistent questions.

Authors:  A Charles; Kc Brennan
Journal:  Cephalalgia       Date:  2009-10       Impact factor: 6.292

Review 8.  Migraine as a systemic vasculopathy.

Authors:  G E Tietjen
Journal:  Cephalalgia       Date:  2009-09       Impact factor: 6.292

9.  Prevalence and sex-ratio of the subtypes of migraine.

Authors:  M B Russell; B K Rasmussen; P Thorvaldsen; J Olesen
Journal:  Int J Epidemiol       Date:  1995-06       Impact factor: 7.196

Review 10.  Pain mechanisms: labeled lines versus convergence in central processing.

Authors:  A D Bud Craig
Journal:  Annu Rev Neurosci       Date:  2003-03-06       Impact factor: 12.449

View more
  125 in total

Review 1.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

2.  Choroidal thickness measurements in migraine patients during attack-free period.

Authors:  Emine Esra Karaca; Emine Belgin Koçer; Şengül Özdek; Hanife Tuba Akçam; Merve Bahar Ercan
Journal:  Neurol Sci       Date:  2015-08-15       Impact factor: 3.307

3.  Activation of Peripheral and Central Trigeminovascular Neurons by Seizure: Implications for Ictal and Postictal Headache.

Authors:  Agustin Melo-Carrillo; Aaron J Schain; Andrew M Strassman; Rami Burstein
Journal:  J Neurosci       Date:  2020-06-11       Impact factor: 6.167

Review 4.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

5.  Unilateral headache with visual aura from a Wallenberg syndrome.

Authors:  Jin Zhu; Jia-Lin Li; Yi-Min Liu; Yuan-Yuan Han; Yu Wang
Journal:  CNS Neurosci Ther       Date:  2012-05-17       Impact factor: 5.243

Review 6.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

Review 7.  The Role of Endothelin in the Pathophysiology of Migraine-a Systematic Review.

Authors:  Afrim Iljazi; Cenk Ayata; Messoud Ashina; Anders Hougaard
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

Review 8.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

Review 9.  Cortical spreading depression and migraine.

Authors:  Andrew C Charles; Serapio M Baca
Journal:  Nat Rev Neurol       Date:  2013-09-17       Impact factor: 42.937

10.  Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas.

Authors:  L Becerra; J Bishop; G Barmettler; Y Xie; E Navratilova; F Porreca; D Borsook
Journal:  J Neurophysiol       Date:  2015-10-21       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.